Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBIT Margin (2020 - 2025)

Historic EBIT Margin for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to 2.04%.

  • LifeStance Health's EBIT Margin rose 20200.0% to 2.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 59100.0%. This contributed to the annual value of 2.53% for FY2024, which is 153900.0% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's EBIT Margin is 2.04%, which was up 20200.0% from 0.85% recorded in Q2 2025.
  • LifeStance Health's 5-year EBIT Margin high stood at 2.04% for Q3 2025, and its period low was 71.72% during Q3 2021.
  • Moreover, its 5-year median value for EBIT Margin was 13.5% (2023), whereas its average is 17.94%.
  • As far as peak fluctuations go, LifeStance Health's EBIT Margin tumbled by -743500bps in 2021, and later skyrocketed by 538600bps in 2022.
  • Over the past 5 years, LifeStance Health's EBIT Margin (Quarter) stood at 59.87% in 2021, then soared by 66bps to 20.06% in 2022, then skyrocketed by 43bps to 11.5% in 2023, then soared by 103bps to 0.33% in 2024, then surged by 526bps to 2.04% in 2025.
  • Its last three reported values are 2.04% in Q3 2025, 0.85% for Q2 2025, and 0.48% during Q1 2025.